Glow vs Wolverine Stack: Skin & Collagen Blend vs Pure Tissue Repair

Glow and the Wolverine Stack overlap — both contain BPC-157 and TB-500 — but they are built for different jobs. Glow (glow) is a GHK-Cu-dominant blend aimed at skin, hair, and collagen. The Wolverine Stack (wolverine) is the pure injury-repair pair, BPC-157 + TB-500, with no copper peptide.

TL;DR: Glow (GHK-Cu + BPC-157 + TB-500) is a single-vial skin/collagen/healing blend led by its copper-peptide backbone. The Wolverine Stack (BPC-157 + TB-500) is two independently dosed repair peptides for tendon, ligament, and muscle. Choose Glow for skin and anti-aging; choose Wolverine for a targeted injury. They share two of three ingredients, but the GHK-Cu backbone is what makes Glow a skin product.

Research-use disclosure: For educational purposes only, not medical advice. None of these peptides is FDA-approved; all are research-use-only, and BPC-157/TB-500 are WADA-prohibited. Dosing reflects community protocols. VialBase may earn a commission on vendor links, which does not influence the content here.

At a Glance

The shared BPC-157 + TB-500 pair sits inside both. The difference is what surrounds it: Glow wraps it around a GHK-Cu skin engine; Wolverine strips it down to just the two repair peptides, independently dosed.

What Each Is Built For

Glow is led by GHK-Cu — 50 mg of its ~70 mg vial — the copper-peptide that drives collagen and elastin synthesis, delivers copper to skin and hair, and supports gut tight junctions. BPC-157 and TB-500 (10 mg each) round out the healing side with angiogenesis and cell migration. It is sold as a single pre-mixed vial, which fixes the ratios: you take the whole blend or none of it. Glow’s job is skin renewal and general recovery, not targeted injury work.

The Wolverine Stack is BPC-157 + TB-500 with nothing else — the two most-studied tissue-repair peptides, run together because they are mechanistically complementary (BPC-157 concentrates local repair and can be injected at the injury; TB-500 drives systemic remodeling). Because they are two separate vials, you can front-load TB-500 for an acute injury or inject BPC-157 locally, independently of each other. (See the BPC-157 vs TB-500 comparison for how the two differ.)

The Overlap — and Why It Doesn’t Make Them Interchangeable

Glow contains both Wolverine peptides, so there is real overlap in repair action. But two things keep them distinct:

1. GHK-Cu changes the purpose. Glow’s copper-peptide backbone is 70% of the vial by mass and makes it a skin/collagen product. The Wolverine Stack has none — it is purely repair.
2. Ratio lock vs independent dosing. In Glow, BPC-157 and TB-500 are fixed at 10 mg each inside a GHK-Cu-heavy blend; you cannot raise TB-500 for weekly loading or inject BPC-157 locally without also taking GHK-Cu. Wolverine lets you dose each to its own optimal schedule.

So Glow gives you some Wolverine-style repair as part of a skin blend, while Wolverine gives you precise, tunable repair.

Which Should You Choose?

• Skin, hair, collagen, anti-aging → Glow. The GHK-Cu backbone is the point; Wolverine has none.
• A specific tendon, ligament, or muscle injury → Wolverine Stack. Independent dosing plus local BPC-157 injection make it the precise tool.
• Acute injury needing a strong start → Wolverine, front-loading TB-500 alongside local BPC-157.
• Inflammatory skin or gut component → neither exactly; consider KLOW (Glow + KPV) for anti-inflammatory coverage.
• Broad skin + healing in one injection → Glow. It covers skin, collagen, and general repair in a single vial, at the cost of tunability.

For full protocols with per-component unit math, see the Glow dosage chart, the individual BPC-157 and TB-500 dosage charts, and the Glow and Wolverine stack profiles.

Dosing

Glow (single vial): reconstitute with 2 mL bacteriostatic water and inject 10–20 units (0.1–0.2 mL) subcutaneously daily, starting at 10 units. Some users dose every other day to moderate TB-500 accumulation.

Wolverine Stack (two vials, never mixed in one syringe): BPC-157 250–500 mcg 1–2x daily, often injected near the injury; TB-500 2–5 mg twice weekly for 4–6 weeks (loading), then ~2 mg weekly, injected subcutaneously anywhere.

Frequently Asked Questions

What is the difference between Glow and the Wolverine Stack? They target different goals. Glow is a GHK-Cu-dominant three-peptide blend (GHK-Cu + BPC-157 + TB-500) built for skin radiance, hair, collagen, and general healing. The Wolverine Stack is BPC-157 + TB-500 — the same two repair peptides Glow contains, but without the copper peptide, dosed as two independent vials for targeted tendon, ligament, and muscle repair. Glow is skin-and-collagen focused; Wolverine is pure tissue repair.

Which is better for skin, Glow or Wolverine? Glow, clearly. Its GHK-Cu backbone (50 mg of a ~70 mg vial) is the copper-peptide engine for collagen, elastin, and skin remodeling — the whole reason Glow exists. The Wolverine Stack has no GHK-Cu; it is built for injury repair, not cosmetic skin work.

Which is better for an injury, Glow or Wolverine? The Wolverine Stack. It delivers BPC-157 and TB-500 at independently controllable doses — BPC-157 can be injected locally at the injury and TB-500 front-loaded for acute recovery. Glow contains both peptides at 10 mg each but at fixed blend ratios alongside GHK-Cu, so it is less tunable for a dedicated injury protocol.

Do Glow and Wolverine share ingredients? Yes — both contain BPC-157 and TB-500. Glow adds GHK-Cu on top (making it skin-focused); the Wolverine Stack is just those two repair peptides. So Glow gives you some of the same tissue-repair action inside a wider skin/collagen blend, while Wolverine gives you precise, tunable repair and nothing else.

Are Glow and the Wolverine Stack FDA-approved? No. Every peptide in both is research-use-only in the US, none is on the 503A bulks list, and BPC-157 and TB-500 are WADA-prohibited. Community dosing guides are a starting point, not medical advice. Avoid with active cancer or during pregnancy.